Regeneron Pharmaceuticals Inc (REGN) — Technical state

As of 2026-10-23 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Stochastic turned down

Its stochastic crossed down from overbought (%K 88.2 under %D 89.4) today — momentum is cooling.

The moving-average stack

vs 20-day+5.1%
vs 50-day+1.7%
vs 200-day+9.4%
52-week band6.3% off the high · +49.2% off the low
Streak1 consecutive down session
50-day crossprice crossed up through the 50-day 4 sessions ago
Stochastic%K 88.2 · %D 89.4 · down cross

Continue: the REGN chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-23

Quick answers

What is the current Closelooknet signal on REGN?

Stochastic turned down — Its stochastic crossed down from overbought (%K 88.2 under %D 89.4) today — momentum is cooling. As of 2026-10-23; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is REGN above its 50-day and 200-day moving averages?

As of 2026-10-23, Regeneron Pharmaceuticals Inc trades +1.7% above its 50-day and +9.4% above its 200-day average, with the 20-day +5.1% away.

How far is REGN from its 52-week high?

6.3% below the 52-week high and 49.2% above the 52-week low, as of 2026-10-23.

Mentioned on Closelooknet

Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000Midday 10 · 21 Aug 2026Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.